logo
#

Latest news with #JasonBeach

Stryker completes sale of U.S. spinal implants business
Stryker completes sale of U.S. spinal implants business

Yahoo

time01-04-2025

  • Business
  • Yahoo

Stryker completes sale of U.S. spinal implants business

Portage, Michigan, April 01, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK), a global leader in medical technologies, announced today that it has completed the sale of its U.S. spinal implants business to Viscogliosi Brothers, LLC, as part of the newly formed company VB Spine, LLC. 'The sale of our spinal implants business enhances our strategic focus, positioning us to meet evolving customer needs and invest where we see the greatest opportunity for innovation and long-term growth,' said Kevin Lobo, Chair and CEO, Stryker. 'We remain committed to the spine space through our Interventional Spine, Neurotechnology and Enabling Technologies businesses, as well as our strategic partnership with VB Spine. We're grateful to our Spine team members for their contributions and confident they're well positioned for continued success.' VB Spine will have exclusive access to Mako Spine and Copilot for use with its implants in spine procedures. Certain international markets are expected to transfer to VB Spine at later dates, subject to the completion of all legal and regulatory requirements and required consultations with employees and/or employee representatives. About Stryker Stryker is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Alongside our customers around the world, we impact more than 150 million patients annually. More information is available at Contacts For investor inquiries:Jason Beach, Vice President, Finance and Investor Relations at 269-385-2600 or For media inquiries: Kim Montagnino, Chief Communications Officer at 269-385-2600 or

Stryker to participate in Citi's 2025 Unplugged Medtech and Life Sciences Access Day
Stryker to participate in Citi's 2025 Unplugged Medtech and Life Sciences Access Day

Yahoo

time13-02-2025

  • Business
  • Yahoo

Stryker to participate in Citi's 2025 Unplugged Medtech and Life Sciences Access Day

Portage, Michigan, Feb. 13, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) will participate in Citi's 2025 Unplugged Medtech and Life Sciences Access Day on Thursday, February 27, 2025 at Citigroup Headquarters, New York, New York. Stryker's management will represent the Company in a presentation scheduled for 12:15 p.m. Eastern Time. A simultaneous webcast and replay of the Company's presentation will be available on Stryker's website at The webcast will be archived on the Investor Relations page of this site. About Stryker Stryker is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Alongside our customers around the world, we impact more than 150 million patients annually. More information is available at Contacts For investor inquiries please contact:Jason Beach, Vice President, Finance and Investor Relations at 269-385-2600 or For media inquiries please contact:Yin Becker, Vice President, Chief Corporate Affairs Officer at 269-385-2600 or in to access your portfolio

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store